CPRT vs CSTL · P/E 19, rev $3.51B vs rev $187.2M
Copart Inc (CPRT) versus Castle Biosciences Inc (CSTL) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. CSTL currently screens at market cap $570.2M.
Not investment advice. Open the CPRT and CSTL stock pages for the full models.
Not investment advice.